|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4361549A
(en)
|
1979-04-26 |
1982-11-30 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
|
|
US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
|
FR2540122B1
(fr)
|
1983-01-27 |
1985-11-29 |
Centre Nat Rech Scient |
Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
|
|
JP2624470B2
(ja)
|
1984-10-02 |
1997-06-25 |
バイオジェン インコーポレイテッド |
ストレプトアビジン様ポリペプチドの製造
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
|
IN165717B
(enExample)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
|
US4851341A
(en)
|
1986-12-19 |
1989-07-25 |
Immunex Corporation |
Immunoaffinity purification system
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
ATE114507T1
(de)
|
1988-12-28 |
1994-12-15 |
Stefan Miltenyi |
Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
|
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
|
ATE159548T1
(de)
|
1990-11-13 |
1997-11-15 |
Immunex Corp |
Bifunktionelle wählbare fusionsgene
|
|
DE4123760C2
(de)
|
1991-07-18 |
2000-01-20 |
Dade Behring Marburg Gmbh |
Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
|
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
DE4237113B4
(de)
|
1992-11-03 |
2006-10-12 |
"Iba Gmbh" |
Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins
|
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
CA2164226C
(en)
|
1993-06-04 |
2011-02-08 |
Carl H. June |
Methods for selectively stimulating proliferation of t cells
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
WO1996013593A2
(en)
|
1994-10-26 |
1996-05-09 |
Procept, Inc. |
Soluble single chain t cell receptors
|
|
WO1996018105A1
(en)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Single chain t-cell receptor
|
|
US5753499A
(en)
|
1994-12-23 |
1998-05-19 |
New York University |
Viral vector complexes having adapters of predefined valence
|
|
WO1996024606A1
(en)
|
1995-02-09 |
1996-08-15 |
University Of Washington |
Modified-affinity streptavidin
|
|
US5840306A
(en)
|
1995-03-22 |
1998-11-24 |
Merck & Co., Inc. |
DNA encoding human papillomavirus type 18
|
|
WO1997011183A1
(en)
|
1995-04-11 |
1997-03-27 |
Trustees Of Boston University |
Streptavidin mutants
|
|
US20020150914A1
(en)
|
1995-06-30 |
2002-10-17 |
Kobenhavns Universitet |
Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
|
|
US6261554B1
(en)
|
1995-07-25 |
2001-07-17 |
Introgene B.V. |
Compositions for targeted gene delivery
|
|
US5801115A
(en)
|
1995-09-05 |
1998-09-01 |
Kataleuna Gmbh |
Catalyst composition and methods for using and preparing same
|
|
US5773224A
(en)
|
1996-02-12 |
1998-06-30 |
Grandics; Peter |
Immunoselection system for cell elution
|
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
|
ATE186235T1
(de)
|
1996-04-24 |
1999-11-15 |
Claude Fell |
Zelltrennungsvorrichtung für biologische flüssigkeiten wie blut
|
|
DE19641876B4
(de)
|
1996-10-10 |
2011-09-29 |
Iba Gmbh |
Streptavidinmuteine
|
|
CA2283716A1
(en)
|
1997-03-14 |
1998-09-17 |
Gabriel O. Reznik |
Multiflavor streptavidin
|
|
CA2305630C
(en)
|
1997-10-02 |
2012-11-06 |
Sunol Molecular Corporation |
Soluble single-chain t-cell receptor proteins
|
|
US5985658A
(en)
|
1997-11-14 |
1999-11-16 |
Health Research Incorporated |
Calmodulin-based cell separation technique
|
|
NZ507886A
(en)
|
1998-05-19 |
2003-05-30 |
Avidex Ltd |
Multivalent T cell receptor complexes
|
|
WO2000014257A1
(en)
|
1998-09-04 |
2000-03-16 |
Sloan-Kettering Institute For Cancer Research |
Fusion receptors specific for prostate-specific membrane antigen and uses thereof
|
|
AU2472400A
(en)
|
1998-10-20 |
2000-05-08 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
ES2224726T3
(es)
|
1998-12-24 |
2005-03-01 |
Biosafe S.A. |
Sistema de separacion sanguinea indicado en particular para la concentracion de celulas madre hematopoyeticas.
|
|
US6664042B1
(en)
|
1999-01-26 |
2003-12-16 |
Cornell Research Foundation, Inc. |
Determining viral load in double negative T cells
|
|
MXPA01007820A
(es)
|
1999-02-04 |
2003-06-19 |
Technion Res & Dev Foundation |
Metodo y aparato para mantenimiento y expansion de celulas de tallo hemopoyeticas y/o celulas progenitoras.
|
|
US20030235908A1
(en)
|
2000-02-24 |
2003-12-25 |
Xcyte Therapies, Inc. |
Activation and expansion of cells
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
DE60127113T2
(de)
|
2000-04-25 |
2007-06-14 |
Otsuka Pharmaceutical Co., Ltd. |
Gd3-mimetische peptide
|
|
CA2410510A1
(en)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Artificial antigen presenting cells and methods of use thereof
|
|
US7446179B2
(en)
|
2000-11-07 |
2008-11-04 |
City Of Hope |
CD19-specific chimeric T cell receptor
|
|
EP1227321A1
(en)
|
2000-12-28 |
2002-07-31 |
Institut für Bioanalytik GmbH |
Reversible MHC multimer staining for functional purification of antigen-specific T cells
|
|
DE10113776B4
(de)
|
2001-03-21 |
2012-08-09 |
"Iba Gmbh" |
Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
|
PT1421115E
(pt)
|
2001-08-31 |
2005-07-29 |
Avidex Ltd |
Receptor de celulas t soluvel
|
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
US8076452B2
(en)
|
2002-03-01 |
2011-12-13 |
Erdmann Volker A |
Streptavidin-binding peptide
|
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
|
US7754155B2
(en)
|
2002-03-15 |
2010-07-13 |
Ross Amelia A |
Devices and methods for isolating target cells
|
|
US20050271653A1
(en)
|
2002-04-23 |
2005-12-08 |
Meir Strahilevitz |
Methods and devices for targeting a site in a mammal and for removing species from a mammal
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
FR2841905B1
(fr)
|
2002-07-05 |
2004-09-03 |
Centre Nat Rech Scient |
Fragments fab mutants de l'anticorps anti-cd4 chimere 13b8.2 et leurs applications
|
|
AU2003246690B2
(en)
|
2002-07-17 |
2010-03-11 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
|
EP1569510B1
(en)
|
2002-09-27 |
2011-11-02 |
The General Hospital Corporation |
Microfluidic device for cell separation and uses thereof
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
|
EP1641911A2
(en)
|
2003-05-02 |
2006-04-05 |
Insception Bioscience, Inc. |
Apparatus and methods for amplification of blood stem cell numbers
|
|
WO2004104185A1
(en)
|
2003-05-08 |
2004-12-02 |
Xcyte Therapies, Inc. |
Generation and isolation of antigen-specific t cells
|
|
US7943393B2
(en)
|
2003-07-14 |
2011-05-17 |
Phynexus, Inc. |
Method and device for extracting an analyte
|
|
US20080050795A1
(en)
|
2003-11-20 |
2008-02-28 |
Biosensor Applications Sweden Ab |
Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture
|
|
SE0400181D0
(sv)
|
2004-01-29 |
2004-01-29 |
Gyros Ab |
Segmented porous and preloaded microscale devices
|
|
US20090304679A1
(en)
|
2004-05-27 |
2009-12-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
US20090226474A1
(en)
|
2004-05-27 |
2009-09-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
US20060034850A1
(en)
|
2004-05-27 |
2006-02-16 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
EP1766400B1
(en)
|
2004-06-03 |
2009-04-15 |
Meso Scale Technologies, LLC |
Methods for conducting whole blood assays
|
|
EP1791865B1
(en)
|
2004-06-29 |
2010-07-28 |
Immunocore Ltd. |
Cells expressing a modified t cell receptor
|
|
EP1809669A2
(en)
|
2004-10-01 |
2007-07-25 |
Avidex Ltd |
T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
|
|
JP5255841B2
(ja)
|
2004-10-15 |
2013-08-07 |
ジェネンコー・インターナショナル・インク |
競合示差スクリーニング
|
|
WO2006058226A2
(en)
|
2004-11-24 |
2006-06-01 |
The Trustees Of Boston University |
Modified dimeric streptavidins and uses thereof
|
|
US20060252087A1
(en)
|
2005-01-18 |
2006-11-09 |
Biocept, Inc. |
Recovery of rare cells using a microchannel apparatus with patterned posts
|
|
US20080171951A1
(en)
|
2005-03-23 |
2008-07-17 |
Claude Fell |
Integrated System for Collecting, Processing and Transplanting Cell Subsets, Including Adult Stem Cells, for Regenerative Medicine
|
|
BRPI0616446A2
(pt)
|
2005-09-28 |
2011-06-21 |
Cytos Biotechnology Ag |
composição contendo conjugados de interleucina-1, vacina, uso da vacina, composição farmacêutica, processo para a produção da composição ou da vacina, bem como medicamento
|
|
US8586708B2
(en)
|
2005-10-28 |
2013-11-19 |
Massachusetts Institute Of Technology |
Monovalent streptavidin compositions
|
|
US7704708B2
(en)
|
2006-02-13 |
2010-04-27 |
Uti Limited Partnership |
Monomeric streptavidin muteins
|
|
US7855057B2
(en)
|
2006-03-23 |
2010-12-21 |
Millipore Corporation |
Protein splice variant/isoform discrimination and quantitative measurements thereof
|
|
WO2007117602A2
(en)
|
2006-04-07 |
2007-10-18 |
Biogen Idec Ma Inc. |
Isolation and use of human regulatory t cells
|
|
US20070238169A1
(en)
|
2006-04-11 |
2007-10-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell sorter and culture system
|
|
US20080085532A1
(en)
|
2006-09-18 |
2008-04-10 |
Jorn Gorlach |
Method for determining the immune status of a subject
|
|
WO2008035631A1
(fr)
|
2006-09-20 |
2008-03-27 |
Kyowa Hakko Kogyo Co., Ltd. |
Procédé de production d'une substance
|
|
CA2915560A1
(en)
|
2006-10-17 |
2008-04-24 |
Tomoaki Fujioka |
Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
|
|
CA2668001C
(en)
|
2006-11-02 |
2016-05-03 |
Kyowa Medex Co., Ltd. |
A method of immunoassaying a component to be measured in a sample containing hemoglobin
|
|
US20080255004A1
(en)
|
2006-11-15 |
2008-10-16 |
Invitrogen Dynal As |
Methods of reversibly binding a biotin compound to a support
|
|
CN101226118B
(zh)
|
2007-01-19 |
2010-06-16 |
中国医学科学院肿瘤研究所 |
一种兼容免疫荧光分析的细胞化学染色方法及其用途
|
|
KR20080076622A
(ko)
|
2007-02-16 |
2008-08-20 |
포항공과대학교 산학협력단 |
올리고머화된 단백질 전달체와 이를 이용한 세포내바이러스 벡터 전달 방법
|
|
EP2617827A1
(en)
|
2007-03-26 |
2013-07-24 |
Celexion, LLC |
Method for displaying engineered proteins on a cell surface
|
|
US8361473B2
(en)
|
2007-03-29 |
2013-01-29 |
Technion Research & Development Foundation Ltd. |
Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
|
|
US8389282B2
(en)
|
2007-03-30 |
2013-03-05 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
WO2009003493A2
(en)
|
2007-07-03 |
2009-01-08 |
Dako Denmark A/S |
Mhc multimers, methods for their generation, labeling and use
|
|
EP2193199B1
(en)
|
2007-08-20 |
2013-11-06 |
Nextera AS |
Pvii phage display
|
|
WO2009039854A2
(en)
|
2007-09-27 |
2009-04-02 |
Dako Denmark A/S |
Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
|
|
EP2520643B8
(en)
|
2007-12-07 |
2019-11-27 |
Miltenyi Biotec B.V. & Co. KG |
Sample processing systems and methods
|
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
|
WO2009091826A2
(en)
|
2008-01-14 |
2009-07-23 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
|
|
SG10201704689XA
(en)
|
2008-01-18 |
2017-07-28 |
Harvard College |
Methods of detecting signatures of disease or conditions in bodily fluids
|
|
EP2245054B1
(en)
|
2008-01-30 |
2018-11-28 |
Pieris Pharmaceuticals GmbH |
Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
|
|
US8093053B2
(en)
|
2008-03-17 |
2012-01-10 |
Uti Limited Partnership |
Methods and compositions for culturing of neural precursor cells
|
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
|
CN101446576B
(zh)
|
2008-12-29 |
2011-06-22 |
江苏省苏微微生物研究有限公司 |
一种微囊藻毒素-lr单抗免疫亲和柱的制备和使用方法
|
|
WO2010080032A2
(en)
|
2009-01-09 |
2010-07-15 |
Stichting Het Nederlands Kanker Instituut |
Bead-assisted viral transduction
|
|
CN102421801B
(zh)
|
2009-03-10 |
2016-03-16 |
比奥根Ma公司 |
抗-bcma抗体
|
|
US20110070581A1
(en)
|
2009-04-27 |
2011-03-24 |
Amit Gupta |
Separation of Leukocytes
|
|
US8772008B2
(en)
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
|
EP2468860B1
(en)
|
2009-08-21 |
2015-11-25 |
Asahi Glass Company, Limited |
Transformant and process for production thereof, and process for production of lactic acid
|
|
WO2011044186A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
|
WO2011053971A2
(en)
|
2009-11-02 |
2011-05-05 |
Fina Biosolutions, Llc |
Method for enhancing the sensitivity of antibody based assays
|
|
JP5956342B2
(ja)
|
2009-11-03 |
2016-07-27 |
シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ |
形質導入Ｔ細胞選択のためのトランケート上皮増殖因子レセプタ（ＥＧＦＲｔ）
|
|
SG177025A1
(en)
|
2010-06-21 |
2012-01-30 |
Agency Science Tech & Res |
Hepatitis b virus specific antibody and uses thereof
|
|
US20120321665A1
(en)
|
2009-12-14 |
2012-12-20 |
Benaroya Research Institute At Virginia Mason |
Compositions and methods for treating airway inflammatory diseases
|
|
MX354068B
(es)
|
2010-01-14 |
2018-02-09 |
Organogenesis Inc |
Construcciones de tejido bio-diseñadas por ingenieria y metodos para la produccion y uso de las mismas.
|
|
EP2363501A1
(en)
|
2010-03-02 |
2011-09-07 |
Universitätsklinikum Hamburg-Eppendorf |
Method for isolating target cells
|
|
WO2011130617A2
(en)
|
2010-04-15 |
2011-10-20 |
Smartflow Technologies, Inc. |
An integrated bioreactor and separation system and methods of use thereof
|
|
US9677038B2
(en)
|
2010-06-23 |
2017-06-13 |
Strobbe Pharma Tech Gmbh |
Device and method for industrial cultivation of cells
|
|
EP2601521B1
(en)
|
2010-08-06 |
2018-05-02 |
Ludwig-Maximilians-Universität München |
Identification of t cell target antigens
|
|
WO2012058627A2
(en)
|
2010-10-29 |
2012-05-03 |
Miqin Zhang |
Pre-targeted nanoparticle system and method for labeling biological particles
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
JP5897035B2
(ja)
|
2010-12-14 |
2016-03-30 |
ユニバーシティ オブ メリーランド，ボルチモア |
汎用の抗タグキメラ抗原受容体発現ｔ細胞及びがんを治療する方法
|
|
WO2012081650A1
(ja)
|
2010-12-16 |
2012-06-21 |
株式会社明治 |
遅延型過敏症軽減剤
|
|
WO2012114978A1
(ja)
|
2011-02-21 |
2012-08-30 |
旭硝子株式会社 |
変異体および該変異体の培養方法
|
|
WO2012129514A1
(en)
|
2011-03-23 |
2012-09-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
ES2785081T3
(es)
|
2011-04-01 |
2020-10-05 |
Memorial Sloan Kettering Cancer Center |
Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2
|
|
JP5840857B2
(ja)
|
2011-04-08 |
2016-01-06 |
国立大学法人 東京大学 |
細胞傷害性ｔ細胞誘導用組成物
|
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
|
SI2726600T1
(sl)
|
2011-07-01 |
2017-07-31 |
Amgen Inc. |
Sesalska celična kultura
|
|
ES2682750T5
(en)
|
2011-07-18 |
2025-02-04 |
Iba Lifesciences Gmbh |
Method of reversibly staining a target cell
|
|
US9353161B2
(en)
|
2011-09-13 |
2016-05-31 |
Uti Limited Partnership |
Streptavidin mutein exhibiting reversible binding for biotin and streptavidin binding peptide tagged proteins
|
|
WO2013062365A2
(ko)
|
2011-10-26 |
2013-05-02 |
국립암센터 |
변이 ｃｔｌａ4 유전자 이입 ｔ 세포 및 이를 포함하는 항암 면역치료용 조성물
|
|
WO2013071154A1
(en)
|
2011-11-11 |
2013-05-16 |
Fred Hutchinson Cancer Research Center |
Cyclin a1-targeted t-cell immunotherapy for cancer
|
|
US8497124B2
(en)
|
2011-12-05 |
2013-07-30 |
Factor Bioscience Inc. |
Methods and products for reprogramming cells to a less differentiated state
|
|
EP2814846B1
(en)
|
2012-02-13 |
2020-01-08 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
|
SG11201404991YA
(en)
|
2012-02-23 |
2014-09-26 |
Stage Cell Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
|
WO2013163171A1
(en)
|
2012-04-24 |
2013-10-31 |
Kaufman Dan S |
Method for developing natural killer cells from stem cells
|
|
NZ702108A
(en)
|
2012-05-03 |
2016-09-30 |
Hutchinson Fred Cancer Res |
Enhanced affinity t cell receptors and methods for making the same
|
|
CN110241086A
(zh)
|
2012-06-11 |
2019-09-17 |
威尔逊沃夫制造公司 |
用于过继细胞疗法的改进的细胞培养方法
|
|
WO2013192294A1
(en)
|
2012-06-20 |
2013-12-27 |
Boston 3T Biotechnologies, Inc. |
Cellular therapies for treating and preventing cancers and other immune system disorders
|
|
UA114108C2
(uk)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
|
|
MX382772B
(es)
|
2012-07-13 |
2025-03-11 |
Univ Pennsylvania |
Composición para usarse para prevenir o retardar el rechazo de trasplante de un tejido u órgano trasplantado en un sujeto.
|
|
KR20210149195A
(ko)
|
2012-07-13 |
2021-12-08 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
형질도입된 ｔ 세포의 투여 적합성을 평가하는 방법
|
|
LT2884999T
(lt)
|
2012-08-20 |
2021-04-12 |
Fred Hutchinson Cancer Research Center |
Ląstelinės imunoterapijos būdas ir kompozicijos
|
|
EP2711418B1
(en)
|
2012-09-25 |
2017-08-23 |
Miltenyi Biotec GmbH |
Method for polyclonal stimulation of T cells by flexible nanomatrices
|
|
RU2729401C2
(ru)
|
2012-10-02 |
2020-08-06 |
Мемориал Слоан-Кеттеринг Кэнсер Сентер |
Композиции и способы для иммунотерапии
|
|
US9599590B2
(en)
|
2012-10-12 |
2017-03-21 |
Sage Science, Inc. |
Side-eluting molecular fractionator
|
|
EP2920204B1
(en)
|
2012-11-16 |
2019-09-18 |
IBA GmbH |
Streptavidin muteins and methods of using them
|
|
IL305629A
(en)
|
2013-02-15 |
2023-11-01 |
Univ California |
Chimeric antigen receptor and methods of using it
|
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
EP2997134B1
(en)
|
2013-05-14 |
2020-06-24 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CN103305464B
(zh)
|
2013-06-05 |
2015-04-15 |
南昌大学 |
直接分离cd4+和cd8+淋巴细胞的方法
|
|
CN110511960B
(zh)
|
2013-07-15 |
2023-05-23 |
美国卫生和人力服务部 |
抗人乳头瘤病毒16 e6 t细胞受体
|
|
CN105452448B
(zh)
|
2013-07-15 |
2020-07-28 |
美国卫生和人力服务部 |
制备抗人乳头瘤病毒抗原的t细胞的方法
|
|
EP3027204B1
(en)
|
2013-07-29 |
2022-01-05 |
2seventy bio, Inc. |
Multipartite signaling proteins and uses thereof
|
|
JP6488666B2
(ja)
|
2013-11-22 |
2019-03-27 |
Ａｇｃ株式会社 |
クローニングベクター、発現ベクターおよび形質転換体の製造方法
|
|
NZ759969A
(en)
*
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
EP3097117B1
(en)
*
|
2014-01-21 |
2023-10-04 |
Novartis Ag |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
EP3104866A4
(en)
|
2014-02-14 |
2017-08-02 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
SG10202109752XA
(en)
|
2014-04-07 |
2021-10-28 |
Novartis Ag |
Treatment of cancer using anti-cd19 chimeric antigen receptor
|
|
SG10201808811QA
(en)
|
2014-04-10 |
2018-11-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Method and compositions for cellular immunotherapy
|
|
RS62471B1
(sr)
|
2014-04-16 |
2021-11-30 |
Juno Therapeutics Gmbh |
Metode, kompleti i uređaji za proširenje populacije ćelija
|
|
IL292038B2
(en)
|
2014-04-23 |
2024-12-01 |
Juno Therapeutics Inc |
Methods for enriching or producing immune cell populations for adoptive therapy
|
|
JP6661544B2
(ja)
|
2014-04-24 |
2020-03-11 |
ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング |
遺伝子改変したｔ細胞の自動生成法
|
|
CN106456670B
(zh)
|
2014-04-25 |
2020-01-07 |
蓝鸟生物公司 |
制备过继性细胞疗法的改善方法
|
|
CN106662584B
(zh)
|
2014-04-30 |
2020-05-05 |
Iba股份有限公司 |
分离靶细胞的方法
|
|
EP3166968B1
(en)
|
2014-05-02 |
2021-09-22 |
The Trustees of the University of Pennsylvania |
Compositions and methods of chimeric autoantibody receptor t cells
|
|
WO2015181253A1
(en)
|
2014-05-27 |
2015-12-03 |
Fundación Pública Andaluza Progreso Y Salud |
Neural progenitor cell population
|
|
PT3149031T
(pt)
|
2014-05-29 |
2020-03-25 |
Us Health |
Receptores de células t anti-e7 do papilomavírus humano 16
|
|
CA2956385A1
(en)
|
2014-07-25 |
2016-01-28 |
Theravectys |
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
|
|
WO2016019300A1
(en)
|
2014-07-31 |
2016-02-04 |
Novartis Ag |
Subset-optimized chimeric antigen receptor-containing t-cells
|
|
GB201415344D0
(en)
|
2014-08-29 |
2014-10-15 |
Ucl Business Plc |
Protein
|
|
ES2688035T3
(es)
|
2014-08-29 |
2018-10-30 |
Gemoab Monoclonals Gmbh |
Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
|
|
US10131901B2
(en)
|
2014-10-15 |
2018-11-20 |
Sage Science, Inc. |
Apparatuses, methods and systems for automated processing of nucleic acids and electrophoretic sample preparation
|
|
JP6740234B2
(ja)
*
|
2014-11-05 |
2020-08-12 |
ジュノー セラピューティクス インコーポレイテッド |
形質導入および細胞プロセシングのための方法
|
|
EP3227323B1
(en)
|
2014-12-03 |
2020-08-05 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
|
CN104450614B
(zh)
|
2014-12-05 |
2017-07-07 |
上海安集协康生物技术股份有限公司 |
一种无动物蛋白源的免疫细胞无血清培养基及其使用方法
|
|
HRP20210582T1
(hr)
|
2014-12-05 |
2021-09-03 |
Memorial Sloan Kettering Cancer Center |
Antitijela koja ciljaju antigen sazrijevanja b-stanice i postupci uporabe
|
|
CN113698497A
(zh)
|
2014-12-05 |
2021-11-26 |
纪念斯隆-凯特琳癌症中心 |
靶向b-细胞成熟抗原的嵌合抗原受体及其用途
|
|
AU2015357535B2
(en)
|
2014-12-05 |
2020-05-14 |
Eureka Therapeutics, Inc. |
Antibodies targeting G-protein coupled receptor and methods of use
|
|
CN107429253B
(zh)
|
2014-12-05 |
2021-11-05 |
希望之城公司 |
Cs1靶向性嵌合抗原受体修饰的t细胞
|
|
DK3227339T3
(da)
|
2014-12-05 |
2022-01-10 |
Memorial Sloan Kettering Cancer Center |
Kimæriske antigenreceptorer rettet mod g-protein-koblet receptor og anvendelser deraf
|
|
US10383929B2
(en)
|
2014-12-12 |
2019-08-20 |
Bluebird Bio, Inc. |
BCMA chimeric antigen receptors
|
|
RU2751362C2
(ru)
*
|
2014-12-29 |
2021-07-13 |
Новартис Аг |
Способы получения экспрессирующих химерный антигенный рецептор клеток
|
|
DE102015205759A1
(de)
|
2015-03-31 |
2016-10-06 |
Henkel Ag & Co. Kgaa |
Mittel für keratinhaltige Fasern, enthaltend mindestens ein Copolymer auf Basis von Vinylpyrrolidon und mindestens ein Copolymer aus Basis von Acrylaten
|
|
US20180140602A1
(en)
|
2015-04-07 |
2018-05-24 |
Novartis Ag |
Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
|
|
PL3280729T3
(pl)
|
2015-04-08 |
2022-08-22 |
Novartis Ag |
Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
|
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
|
US10829735B2
(en)
|
2015-07-21 |
2020-11-10 |
The Trustees Of The University Of Pennsylvania |
Methods for improving the efficacy and expansion of immune cells
|
|
HK1256130A1
(zh)
|
2015-07-21 |
2019-09-13 |
City Of Hope |
用於嵌合抗原受体和其他受体的表达的t细胞
|
|
EP4339287A3
(en)
|
2015-07-31 |
2024-05-22 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
MX2018001568A
(es)
|
2015-08-07 |
2019-04-25 |
Seattle Children´S Hospital Dba Seattle Children´S Res Institute |
Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos.
|
|
AU2016325384B2
(en)
|
2015-09-22 |
2021-07-22 |
Julius-Maximilians-Universitat Wurzburg |
A method for high level and stable gene transfer in lymphocytes
|
|
WO2017070333A1
(en)
|
2015-10-20 |
2017-04-27 |
Cellular Dynamics International, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
|
RU2761555C2
(ru)
|
2015-10-22 |
2021-12-09 |
Джуно Терапьютикс Гмбх |
Способы, наборы, средства и устройства для трансдукции
|
|
KR102908806B1
(ko)
|
2015-10-22 |
2026-01-07 |
주노 테라퓨틱스 게엠베하 |
세포의 배양 방법 및 이를 위한 키트와 장치
|
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
|
MX2018006789A
(es)
*
|
2015-12-03 |
2019-02-13 |
Juno Therapeutics Inc |
Receptores quimericos modificados y composiciones y metodos relacionados.
|
|
CA3009852A1
(en)
*
|
2015-12-28 |
2017-07-06 |
Novartis Ag |
Methods of making chimeric antigen receptor-expressing cells
|
|
WO2017156479A1
(en)
|
2016-03-11 |
2017-09-14 |
Bluebird Bio, Inc. |
Ror1 chimeric antigen receptors
|
|
KR20180125999A
(ko)
|
2016-03-17 |
2018-11-26 |
메르크 파텐트 게엠베하 |
폴록사머의 정제 방법
|
|
AU2017235657B2
(en)
|
2016-03-18 |
2022-07-21 |
Fred Hutchinson Cancer Center |
Compositions and methods for CD20 immunotherapy
|
|
KR102427334B1
(ko)
|
2016-04-01 |
2022-08-03 |
카이트 파마 인코포레이티드 |
키메라 항원 및 t 세포 수용체 및 사용 방법
|
|
AU2017248259A1
(en)
|
2016-04-07 |
2018-10-25 |
Bluebird Bio, Inc. |
Chimeric antigen receptor T cell compositions
|
|
WO2017214207A2
(en)
|
2016-06-06 |
2017-12-14 |
Juno Therapeutics, Inc. |
Methods for the treatment of b cell malignancies using adoptive cell therapy
|
|
CN106754670B
(zh)
|
2016-11-30 |
2020-02-14 |
湖南省生宝生物科技有限公司 |
一种间充质干细胞无血清培养基及其配制方法和应用
|
|
WO2018106732A1
(en)
|
2016-12-05 |
2018-06-14 |
Juno Therapeutics, Inc. |
Production of engineered cells for adoptive cell therapy
|
|
US11932870B2
(en)
|
2016-12-05 |
2024-03-19 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
|
CN106635955B
(zh)
|
2016-12-16 |
2020-05-19 |
江苏艾尔康生物医药科技有限公司 |
类角膜内皮细胞的获取方法
|
|
CN106834218B
(zh)
|
2017-01-06 |
2021-03-02 |
沈阳艾米奥生物工程技术研发中心有限公司 |
人羊膜上皮干细胞无血清培养基及其培养方法
|
|
EP3571221A2
(en)
|
2017-01-20 |
2019-11-27 |
Juno Therapeutics GmbH |
Cell surface conjugates and related cell compositions and methods
|
|
CN106801032B
(zh)
|
2017-02-17 |
2021-03-02 |
沈阳艾米奥生物工程技术研发中心有限公司 |
人羊膜上皮干细胞库的构建方法
|
|
EP3372670B1
(en)
|
2017-03-09 |
2019-02-27 |
Evonik Technochemie GmbH |
Culture media comprising n-acyl-x-glutamine dipeptides
|
|
CN110913690A
(zh)
|
2017-03-14 |
2020-03-24 |
朱诺治疗学股份有限公司 |
用于低温储存的方法
|
|
CN110709700A
(zh)
|
2017-04-14 |
2020-01-17 |
朱诺治疗学股份有限公司 |
评估细胞表面糖基化的方法
|
|
AU2018260380B2
(en)
|
2017-04-27 |
2025-02-13 |
Juno Therapeutics Gmbh |
Oligomeric particle reagents and methods of use thereof
|
|
PL3618842T3
(pl)
|
2017-05-01 |
2024-02-19 |
Juno Therapeutics, Inc. |
Kombinacja terapii komórkowej i związku immunomodulującego
|
|
IL327498A
(en)
|
2017-06-02 |
2026-05-01 |
Juno Therapeutics Inc |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
|
US12036241B2
(en)
|
2017-07-19 |
2024-07-16 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
|
KR102755437B1
(ko)
*
|
2017-08-09 |
2025-01-20 |
주노 쎄러퓨티크스 인코퍼레이티드 |
유전자 조작된 세포 조성물 및 관련 조성물의 제조 방법
|
|
EP4516896A3
(en)
*
|
2017-08-09 |
2025-05-14 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
|
CA3080509A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Process for producing a t cell composition
|
|
JP7357626B2
(ja)
|
2017-11-01 |
2023-10-06 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞の治療用組成物を生成するためのプロセス
|
|
AU2018359907A1
(en)
|
2017-11-06 |
2020-05-07 |
Fred Hutchinson Cancer Center |
Combination of a cell therapy and a gamma secretase inhibitor
|
|
CN119193493A
(zh)
|
2017-12-08 |
2024-12-27 |
朱诺治疗学股份有限公司 |
生产工程化t细胞组合物的过程
|
|
AU2018379091A1
(en)
|
2017-12-08 |
2020-06-25 |
Juno Therapeutics, Inc. |
Serum-free media formulation for culturing cells and methods of use thereof
|
|
AU2019206724A1
(en)
|
2018-01-15 |
2020-07-16 |
Kite Pharma, Inc. |
Methods of administering chimeric antigen receptor immunotherapy in combination with 4-1BB agonist
|
|
CN112585276A
(zh)
*
|
2018-04-05 |
2021-03-30 |
朱诺治疗学股份有限公司 |
产生表达重组受体的细胞的方法和相关组合物
|
|
US20210330788A1
(en)
|
2018-07-11 |
2021-10-28 |
Celgene Corporation |
Uses of anti-bcma chimeric antigen receptors
|
|
CN112805378A
(zh)
|
2018-08-09 |
2021-05-14 |
朱诺治疗学股份有限公司 |
用于评估整合核酸的方法
|
|
BR112021002390A2
(pt)
|
2018-08-09 |
2021-05-11 |
Juno Therapeutics Inc |
processos para gerar células modificadas e suas composições
|
|
WO2020089343A1
(en)
|
2018-10-31 |
2020-05-07 |
Juno Therapeutics Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
|
US20230090117A1
(en)
*
|
2020-01-28 |
2023-03-23 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
|
CA3169672A1
(en)
|
2020-02-12 |
2021-08-19 |
Juno Therapeutics, Inc. |
Cd19-directed chimeric antigen receptor t cell compositions and methods and uses thereof
|
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Ｂｃｍａ指向性キメラ抗原受容体ｔ細胞組成物ならびにその方法および使用
|